IL10 and acute respiratory distress syndrome: Moreover, Bustos et al. showed that the anti-inflammatory characteristics of MSCs improved after in vitro activation with serum from patients with acute respiratory distress syndrome (ARDS), demonstrating that activated MSCs increased the production of IL-10 and IL-1RN (interleukin-1 receptor antagonist) [19].